Jefferies Financial Group Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price

Cardinal Health (NYSE:CAH) had its price target upped by analysts at Jefferies Financial Group from $220.00 to $270.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price objective indicates a potential upside of 29.34% from the company’s previous close.

Other research analysts have also issued research reports about the stock. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Leerink Partners set a $240.00 price objective on Cardinal Health in a report on Tuesday, January 13th. TD Cowen boosted their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 3rd. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $190.00 to $244.00 in a research note on Friday, January 9th. Finally, Barclays initiated coverage on Cardinal Health in a research note on Monday, December 8th. They set an “overweight” rating and a $243.00 price target on the stock. Fourteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average target price of $219.67.

Cardinal Health Trading Up 0.1%

Shares of CAH opened at $208.75 on Thursday. The firm has a market capitalization of $49.60 billion, a P/E ratio of 31.49, a P/E/G ratio of 1.42 and a beta of 0.65. Cardinal Health has a 12-month low of $120.72 and a 12-month high of $215.48. The firm has a fifty day moving average price of $205.71 and a 200-day moving average price of $175.68.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Analysts predict that Cardinal Health will post 7.95 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CAH. Integrated Wealth Concepts LLC raised its stake in Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after purchasing an additional 280 shares during the period. Jones Financial Companies Lllp raised its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in Cardinal Health by 1.3% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 36,267 shares of the company’s stock worth $5,982,000 after buying an additional 477 shares in the last quarter. Fifth Third Bancorp boosted its position in Cardinal Health by 1.9% in the 2nd quarter. Fifth Third Bancorp now owns 14,458 shares of the company’s stock valued at $2,429,000 after buying an additional 268 shares during the period. Finally, Accurate Wealth Management LLC increased its position in shares of Cardinal Health by 92.8% during the second quarter. Accurate Wealth Management LLC now owns 3,627 shares of the company’s stock worth $588,000 after acquiring an additional 1,746 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.